The Pharmaceutical Research and Manufacturers of America (PhRMA) outlined initiatives to bolster U.S. manufacturing, ease patient costs, and improve access to medicine.

The trade group emphasized that these efforts reflect the biopharmaceutical industry’s long-term commitment to American patients and workers.

PhRMA member companies plan to make what the organization described as historic investments in U.S.-based manufacturing and infrastructure.

Also Read: Your AstraZeneca Medicine Could Be Cheaper As Much As 70%

In addition, they will expand financial assistance programs for millions of insured and underinsured patients and launch a new online platform to simplify access to direct purchase programs and support resources.

A major piece of this initiative is AmericasMedicines.com, a website scheduled to go live in January 2026. The site is designed to connect patients ...